We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 24, 2016

Empagliflozin Slows Progression of Kidney Disease in Diabetes

The New England Journal of Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
N. Engl. J. Med 2016 Jun 14;[EPub Ahead of Print], C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, M Mattheus, OE Johansen, HJ Woerle, UC Broedl, B Zinman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading